Effect of ipriflavone on the response of uterus and thyroid to estrogen.
Ipriflavone, 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one, was uterotropic in intact but not in ovariectomized rats. When it was administered simultaneously with estrone and estradiol-17 beta to ovariectomized rats, ipriflavone increased the uterotropic activities of both estrogens. The uterotropic activity of this compound in intact rats might be attributable to its action on the target organ of estrogen by augmenting the response to the hormone because none of the other possibilities for accelerating uterine growth such as gonadotropin-releasing, gonadotropic, and estrogen metabolism-retarding activities were demonstrated experimentally. In addition, ipriflavone increased the calcitonin releasing activity of estrone when these compounds were administered simultaneously to ovariectomized rats.
D000818:Animals; D002116:Calcitonin / Q000097:blood; D002118:Calcium / Q000097:blood; D004347:Drug Interactions; D004958:Estradiol / Q000097:blood / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D007016:Hypophysectomy; D007529:Isoflavones / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010052:Ovariectomy; D051381:Rats; D011919:Rats, Inbred Strains; D013961:Thyroid Gland / Q000187:drug effects / Q000502:physiology*; D014599:Uterus / Q000187:drug effects / Q000254:growth & development*
D004967:Estrogens; D005419:Flavonoids; D007529:Isoflavones; D004970:Estrone; D004958:Estradiol; C018986:ipriflavone; D002116:Calcitonin; D002118:Calcium